Publication Date
3-1-2024
Journal
Eurosurveillance
DOI
10.2807/1560-7917.ES.2024.29.12.2400094
PMID
38516786
PMCID
PMC11063674
PubMedCentral® Posted Date
3-21-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Humans, European Union, Population Surveillance, Tuberculosis, Eastern European People, Tuberculosis, Multidrug-Resistant, tuberculosis, TB, Ukraine, Russia, war, migration, conflict, EU/EEA, COVID-19, DR, drug resistance, RR/MDR, pre-XDR, XDR, Europe
Abstract
Approximately five million Ukrainians were displaced to the EU/EEA following the Russian invasion of Ukraine. While tuberculosis (TB) notification rates per 100,000 Ukrainians in the EU/EEA remained stable, the number of notified TB cases in Ukrainians increased almost fourfold (mean 2019-2021: 201; 2022: 780). In 2022, 71% cases were notified in three countries, and almost 20% of drug-resistant TB cases were of Ukrainian origin. Targeted healthcare services for Ukrainians are vital for early diagnosis and treatment, and preventing transmission.
Included in
Community Health and Preventive Medicine Commons, COVID-19 Commons, Digestive System Diseases Commons, Epidemiology Commons, Gastroenterology Commons, Hepatology Commons, International Public Health Commons, Medical Sciences Commons, Pediatrics Commons